ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,513, issued on Jan. 27, was assigned to Centivax Inc. (South San Francisco, Calif.).
"Anti-SARS-CoV-2 antibodies derived from 2DD8" was invented by Jacob Glanville (San Francisco), Shahrad Daraeikia (San Francisco), I-Chieh Wang (San Bruno, Calif.), Sindy Andrea Liao Chan (San Jose, Calif.), Jean-Philippe Burckert (Belmont, Calif.) and Sawsan Youssef (Menlo Park, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides antibodies and antigen-binding fragments that can be administered to an individual that is infected or suspected of being infected with a virus. Antibodies and antigen-binding fragments herein can be capable of t...